Mortality rates in Appalachia have progressively increased over recent years, in contrast to decreasing mortality rates observed in the remainder of the US. West Virginia was ranked 47th overall among the 50 states in the 2015 America's Health Rankings. In addition, WV remains at, or near, the bottom for a number of chronic diseases including cancer and cardiovascular disease. These observations alone do not capture the entire continuum of health related challenges in the state or region, but clearly emphasize the need for continued focus on, and investment in, research that underpins real solutions. The West Virginia Clinical and Translational Science Institute (WVCTSI) was created in 2012 through the initial Clinical and Translational Research (CTR) award and has subsequently formed a well-connected, statewide research network, creating the infrastructure to address the substantial health disparities that exist in West Virginia. The overarching goal of the WVCTSI is to serve as a collaborative hub to lead statewide innovation in clinical and translational research, catalyzing and accelerating development of solutions to vexing health problems. Over the past four years, WVCTSI has been a transformative force, implementing investigator mentoring services, establishing pilot project funding, forming a practice-based research network of 68 sites (mostly rural), creating an integrated data repository of two million unique electronic medical records, developing a broad-based culture of research integrity, and working with our partners to establish trust and effective collaboration. WVCTSI is now well positioned to attain the goals of this renewal application that include: 1) building sustainable research infrastructure that substantively contributes to improving WV health outcomes by 2022, 2) recruiting the next generation of clinician scientists and translational researchers that excel in team science and are positioned for long-term success, and 3) actively engaging with multiple stakeholders that include communities, medical providers, and policy makers to drive research that improves health of West Virginians. Our partners include all academic medical centers within the state as well as the University of Kentucky, the Veterans Administration, and the National Institute for Occupational Safety and Health. Through its collective activities and powerful partnerships, the WVCTSI will play a critical role in reversing the trend of increasing mortality rates in West Virginia and serve as a model for developing effective research infrastructure that provides solutions to regional health issues.

Public Health Relevance

Mortality rates in Appalachia have progressively increased over recent years, in contrast to decreasing rates observed in the remainder of the United States. The overarching goal of this renewal application is to serve as a collaborative hub, leading statewide innovation in clinical and translational research to catalyze and accelerate the development of solutions to improve health disparity outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54GM104942-05S2
Application #
10210187
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Gao, Hongwei
Project Start
2012-08-15
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
West Virginia University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Conway, B N; Lopes-Virella, M F; Blot, W J (2018) Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis. Diabet Med 35:729-736
Kenamond, Mark C; Siochi, R Alfredo; Mattes, Malcolm D (2018) The dosimetric effects of limited elective nodal irradiation in volumetric modulated arc therapy treatment planning for locally advanced non-small cell lung cancer. J Radiat Oncol 7:45-51
Mousa, Albeir Y; Broce, Mike; De Wit, David et al. (2018) Appropriate Use of Venous Imaging and Analysis of the D-Dimer/Clinical Probability Testing Paradigm in the Diagnosis and Location of Deep Venous Thrombosis. Ann Vasc Surg 50:21-29
Petty, Aaron; Idippily, Nethrie; Bobba, Viharika et al. (2018) Design and synthesis of small molecule agonists of EphA2 receptor. Eur J Med Chem 143:1261-1276
Hylin, Michael J; Holden, Ryan C; Smith, Aidan C et al. (2018) Juvenile Traumatic Brain Injury Results in Cognitive Deficits Associated with Impaired Endoplasmic Reticulum Stress and Early Tauopathy. Dev Neurosci 40:175-188
Breckenridge, Charles B; Foradori, Chad D; Sawhney Coder, Pragati et al. (2018) Changes in Sensitivity to the Effects of Atrazine on the Luteinizing Hormone Surge in Female Sprague-Dawley Rats after Repeated Daily Doses: Correlation with Liver Enzyme Expression. Birth Defects Res 110:246-258
Feinberg, Termeh; Jones, Dina L; Lilly, Christa et al. (2018) The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain. PLoS One 13:e0196390
Sedney, Cara L; Haggerty, Treah; Patricia Dekeseredy, R N (2018) A Short Weight Loss Intervention in a Neurosurgical Subspecialist Clinical Setting. J Neurosci Rural Pract 9:492-495
Loskutov, Yuriy V; Griffin, Caryn L; Marinak, Kristina M et al. (2018) LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. Oncogene 37:1457-1471
Mason, Ivy C; Boubekri, Mohamed; Figueiro, Mariana G et al. (2018) Circadian Health and Light: A Report on the National Heart, Lung, and Blood Institute's Workshop. J Biol Rhythms 33:451-457

Showing the most recent 10 out of 998 publications